Utilization of quantitative in vivo pharmacology approaches to assess combination effects of everolimus and irinotecan in mouse xenograft models of colorectal cancer

Utilization of quantitative in vivo pharmacology approaches to assess combination effects of everolimus and irinotecan in mouse xenograft models of colorectal cancer

Item
http://www.wikidata.org/entity/Q34631723
Investigation of the Material Basis Underlying the Correlation between Presbycusis and Kidney Deficiency in Traditional Chinese Medicine via GC/MS MetabolomicsMRS-based Metabolomics in Cancer Research.Combined inhibition of MEK and Aurora A kinase in KRAS/PIK3CA double-mutant colorectal cancer models.Comparative Metabolomic Profiling of Hepatocellular Carcinoma Cells Treated with Sorafenib Monotherapy vs. Sorafenib-Everolimus Combination Therapy.A phase I trial of everolimus in combination with 5-FU/LV, mFOLFOX6 and mFOLFOX6 plus panitumumab in patients with refractory solid tumors.Molecular characterization of colorectal cancer patients and concomitant patient-derived tumor cell establishment.Antitumor activity of the aurora a selective kinase inhibitor, alisertib, against preclinical models of colorectal cancer.Targeting mTOR network in colorectal cancer therapyAssessment of non-linear combination effect terms for drug-drug interactions.Environmental influences in the etiology of colorectal cancer: the premise of metabolomics.HSP90 inhibitor 17-DMAG exerts anticancer effects against gastric cancer cells principally by altering oxidant-antioxidant balance.Phospho-mTOR in non-tumour and tumour bladder urothelium: Pattern of expression and impact on urothelial bladder cancer patients.Characterization of the transcriptional and metabolic responses of pediatric high grade gliomas to mTOR-HIF-1α axis inhibition.Mitochondrial phosphoenolpyruvate carboxykinase (PEPCK-M) regulates the cell metabolism of pancreatic neuroendocrine tumors (pNET) and de-sensitizes pNET to mTOR inhibitors.Everolimus Plus Ku0063794 Regimen Promotes Anticancer Effects against Hepatocellular Carcinoma Cells through the Paradoxical Inhibition of Autophagy.
P2860

Utilization of quantitative in vivo pharmacology approaches to assess combination effects of everolimus and irinotecan in mouse xenograft models of colorectal cancer

Item
http://www.wikidata.org/entity/Q34631723
description
2013 nî lūn-bûn
@nan
2013 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մարտին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Utilization of quantitative in ...... ft models of colorectal cancer
@ast
Utilization of quantitative in ...... ft models of colorectal cancer
@en
Utilization of quantitative in ...... ft models of colorectal cancer
@nl
type
label
Utilization of quantitative in ...... ft models of colorectal cancer
@ast
Utilization of quantitative in ...... ft models of colorectal cancer
@en
Utilization of quantitative in ...... ft models of colorectal cancer
@nl
prefLabel
Utilization of quantitative in ...... ft models of colorectal cancer
@ast
Utilization of quantitative in ...... ft models of colorectal cancer
@en
Utilization of quantitative in ...... ft models of colorectal cancer
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P921
P932
P356
P1433
P1476
Utilization of quantitative in ...... ft models of colorectal cancer
@en
P2093
P2860
P304
P31
P356
10.1371/JOURNAL.PONE.0058089
P407
P433
P478
P577
P5875
P698
P921
P932